Table 1.
WBC count | Treatmentsa | P-valueb | |||
---|---|---|---|---|---|
CON | 5-HTP | FLX | 5-HTP vs. CON | FLX vs. CON | |
Neutrophils, 103/μL | 3.69 ± 0.62 | 3.96 ± 0.67 | 3.69 ± 0.62 | 0.78 | 0.99 |
Monocytes, 103/μL | 1.08 ± 0.11 | 1.19 ± 0.12 | 0.97 ± 0.11 | 0.51 | 0.48 |
Lymphocytes, 103/μL | 4.37 ± 0.23 | 4.79 ± 0.24 | 4.79 ± 0.23 | 0.22 | 0.48 |
Eosinophils, 103/μL | 0.06 ± 0.02 | 0.06 ± 0.22 | 0.09 ± 0.02 | 0.96 | 0.42 |
Basophils, 103/μL | 0.01 ± 0.02 | 0.05 ± 0.03 | 0.03 ± 0.02 | 0.26 | 0.71 |
aOral supplementation of milk replacer with saline (control; n = 8), fluoxetine (40 mg/d; n = 8) or 5-hydroxytryptophan (5-HTP, 90 mg/d; n = 8) to Holstein dairy calves for 10 consecutive days.
bStatistical significance declared at P-value ≤ 0.05 and tendencies at 0.05 < P ≤ 0.10.